Mitomycin-C for HPV-positive and HPV-negative platinum-refractory, recurrent or metastatic head and neck squamous cell carcinoma: A phase 2 trial

Authors

Peter Oppelt, Washington University School of Medicine in St. Louis
Jessica Ley, Washington University School of Medicine in St. Louis
Christine Auberle, Washington University School of Medicine in St. Louis
Brendan Knapp, Washington University School of Medicine in St. Louis
Jesse Zaretsky, Washington University School of Medicine in St. Louis
Fei Wan, Washington University School of Medicine in St. Louis
Douglas Adkins, Washington University School of Medicine in St. Louis

Journal

Cancers

Publication Date

11-4-2025

Volume

17

Issue

21

First Page

3568

Document Type

Open Access Publication

DOI

10.3390/cancers17213568

Rights and Permissions

Oppelt P, Ley J, Auberle C, Knapp B, Zaretsky J, Wan F, Adkins D. Mitomycin-C for HPV-Positive and HPV-Negative Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial. Cancers (Basel). 2025 Nov 4;17(21):3568. doi: 10.3390/cancers17213568 Copyright: © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/ licenses/by/4.0/).

Recommended Citation

Oppelt, Peter; Ley, Jessica; Auberle, Christine; Knapp, Brendan; Zaretsky, Jesse; Wan, Fei; and Adkins, Douglas, "Mitomycin-C for HPV-positive and HPV-negative platinum-refractory, recurrent or metastatic head and neck squamous cell carcinoma: A phase 2 trial." Cancers. 17, 21. 3568 (2025).
https://digitalcommons.wustl.edu/oa_4/5853

Department

ICTS (Institute of Clinical and Translational Sciences)